Department of Endocrinology and Metabolism, Gulhane School of Medicine
Ankara, 06180, Turkey (Türkiye)
NCT Number: NCT02180191
An altered gut microbiota composition has recently been linked to obesity and diabetes. The principal aim of this study was to investigate and compare the gut microbiota composition of obese, diabetic and control individuals. Then, associations between analyzed gut microbial concentrations and clinical-biochemical blood parameters were assessed.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Ankara, 06180, Turkey (Türkiye)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 9 months
The gut microbiota composition of obese, diabetic and control individuals was analyzed by quantitative real-time PCR (qRT-PCR)
Time frame: 9 months
A multivariate linear regression analysis was performed in order to test associations between the gut microbiota composition and metabolic variables of participants
Gulhane School of Medicine
Other
Comparison of Gut Microbiota in Obese, Diabetic and Healthy Control Individuals
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07619495
Body Weight, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial DetailsNCT02328599
Body Weight, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial DetailsNCT05110846
Body Weight, Diabetes Mellitus
Guadalajara, Jalisco, Mexico
View Trial DetailsNCT05394519
Body Weight, Diabetes Mellitus
Concord, California, United States
View Trial Details